Abstract Body

Background

The interplay between viruses and their hosts is shaped by cellular restriction factors (RFs) that target nearly every step of the viral replication cycle. To overcome these defenses, viruses evolved countermeasures, such as the expression of accessory proteins. Many antiviral factors – and the viral mechanisms that antagonize them – remain unknown. To identify novel RFs, we equipped replication-competent HIV-1 with a sgRNA library targeting host factors (Prelli Bozzo, Laliberté et al., Nat. Com. 2024). In Cas9-expressing cells, viruses carrying sgRNAs against antiviral factors gain a replication advantage, and sequencing of viral supernatants allows identification of the most successful viruses, thereby revealing the targeted host genes. Initially we used a library limited to ~1,500 sgRNAs (~500 genes). Here, we expanded this to a genome-wide HIV-1 sgRNA library and included an HIV-1 variant lacking the accessory protein Vpu.

Methods

We generated replication-competent HIV-1 constructs encoding 77.441 distinct sgRNAs for genome-wide targeting. CEM-M7 cells stably expressing Cas9 were infected and HIV-1 sgRNA libraries were passaged with or without IFN-β. At different timepoints, viral supernatants were collected, and sgRNA enrichment was determined by next-generation sequencing. For validation in primary CD4+ T cells, cells were transduced with Cas9 and infected with replication-competent HIV-1 constructs carrying the sgRNA of interest. To specifically uncover antiviral factors antagonized by the viral accessory protein Vpu, we conducted a parallel screen with vpu-deficient HIV-1 constructs. 

Results

The screens identified numerous potential antiviral factors. These analyses identified a cluster of potential RFs involved in DNA replication and repair (DNaseL1, GNB1L, MPND, NTHL1, POLE4, RMI2). Their antiviral activity was confirmed in primary CD4⁺ T cells, resulting in 2- to 3-fold increase in viral yield for sgRNAs targeting these genes. More than 50 factors, including ADAMTS16, ARFIP1, CEACAM5 and RAB7A, were specifically enriched in the absence of an intact vpu gene (>2 fold-enrichment, p < 0.05), suggesting that they are counteracted by Vpu. Validation of these and other factors in primary CD4+ T cells is ongoing. 

Conclusions

Replication-competent HIV-1-guided CRISPR screens allow highly sensitive and well-reproducible identification of novel restriction factors as well as targets of immune evasion strategies of HIV-1.